HEART UK is supported by experts who guide and advise various aspects of our work.
Medical, Scientific and Research Committee
Chaired by Dr Handrean Soran, Consultant Physician & Endocrinologist, Department of Medicine, Manchester University Hospitals NHS Foundation Trust
Oversee the Annual Conference, the development of research and speciality training programmes, allocation of research awards and clinical guideline development
HEART UK's CVD Collaborative
Chaired by Simon Williams, Head of External Affairs
Advises on public affairs and policy activities to highlight the importance of cholesterol and CVD. Membership includes Amgen, Bayer, Daiichi Sankyo and Novartis and an annual membership fee is paid. All final decisions remain with HEART UK and members have no editorial control over the content or outputs of the Group’s work.
HEART UK Primary Care Education Programme Advisory Group
Chaired by Christopher Allen, Head of Healthcare
Advises on the development and implementation of an education programme for primary care healthcare professionals and further the objectives of the charity to provide learning opportunities on lipid management.
Membership includes Boehringer Ingelheim, Novartis and Sanofi and an annual fee is paid. All final decisions remain with HEART UK and members have no editorial control over the content or outputs of the Primary Care Education Programme Advisory Group’s work.”
Chaired by Michaela Nuttall, Cardiovascular Nurse Specialist
Provides up-to-date information to health care professionals who care for patients and their families with lipid disorders and co-organise the Annual Conference.
Lipid Interest Group
Chaired by Alison Pottle, Nurse Consultant in Cardiology, Harefield Hospital
Education, networking, promoting information and support for people with an interest in lipids i.e. nurses, dieticians across both primary and secondary care.
Lipoprotein Apheresis Working Group
Chaired by Dr Dev Datta, Consultant in Metabolic Medicine, University Hospital of Wales, Cardiff
To promulgate guidance regarding the clinical indications for undertaking lipoprotein apheresis and the criteria of efficacy of its performance in the UK.
Assessment of the latter will be based upon data collected in a Registry, which is set up under the aegis of HEART UK and the Royal College of Physicians. Also to widen the knowledge about Apheresis as a treatment.
Product Approval Working Group
Evaluates products for approval following an ethical and scientific policy framework.
Simon Broome Steering Committee
Chaired by Dr Nigel Capps, Consultant Chemical Pathologist Shrewsbury and Telford Hospital NHS Trust
Responsible for directing research based on a national cohort of over 3,500 patients and familial hypercholesterolaemia. The Sub-Committee is composed of clinical academics, geneticists and clinicians.